Orano Med lays out €250M to build French radioligand factory
15 Nov 2024 //
FIERCE PHARMA
Sanofi and Orano join to develop Next-Gen radioligand medicines
17 Oct 2024 //
GLOBENEWSWIRE
Patient enrollment completed for Phase II trial of AlphaMedix
16 May 2023 //
CLINICAL TRIALS ARENA